n | Median | 25th-75th percentiles | |
---|---|---|---|
Age (years) | 109 | 12.6 | 11.5–13.2 |
Tanner stage | 100 | ||
1 | 20 | ||
2 | 33 | ||
3 | 29 | ||
4 | 16 | ||
5 | 2 | ||
SES | 108 | ||
1 | 57 | ||
2 | 20 | ||
3 | 36 | ||
4 | 5 | ||
5 | 0 | ||
Height (cm) | 109 | 158.3 | 150.9–166.7 |
Height SDS | 109 | 0.11 | -0.65–0.87 |
Weight (kg) | 109 | 44.9 | 38.6–51.5 |
Weight SDS | 109 | 0.01 | -0.73–0.75 |
BMI (kg/m2) | 109 | 17.7 | 16.5–19.8 |
BMI SDS | 109 | 0.30 | -0.83–0.60 |
Body fat assessed by MRI (%) | |||
Abdominal fat | 109 | 18.9 | 16.5–24.8 |
Visceral fat | 109 | 6.47 | 5.69–7.39 |
Body fat assessed by DXA (%) | |||
Total body fat | 108 | 16.8 | 12.8–24.8 |
Total body fat SDS | 108 | -0.08 | -0.63–0.77 |
Android fat | 108 | 16.3 | 11.6–26.7 |
Gynoid fat | 108 | 26.7 | 22.2–35.8 |
Android/gynoid ratio | 108 | 0.6 | 0.51–0.78 |
PFAS serum concentrations (ng/mL) | |||
PFOA | 109 | 2.79 | 2.18–3.58 |
PFOS | 109 | 6.81 | 5.85–9.47 |
PFHxS | 109 | 0.50 | 0.40–0.65 |
PFNA | 109 | 0.92 | 0.73–1.17 |
PFDA | 109 | 0.31 | 0.25–0.37 |